|
시장보고서
상품코드
2074796
정밀 의료 소프트웨어 시장(2026-2030년)Global Precision Medicine Software Market 2026-2030 |
||||||
세계의 정밀 의료 소프트웨어 시장은 2025-2030년 14억 9,670만 달러 증가하고, 예측 기간 중 연평균 복합 성장률(CAGR)은 10.9%를 기록할 것으로 예측됩니다.
세계 정밀 의료 소프트웨어 시장에 관한 본 보고서에서는 종합적인 분석, 시장 규모 및 전망, 동향, 성장 요인, 과제는 물론, 약 25개 업체를 대상으로 한 벤더 분석을 제공합니다.
본 보고서에서는 현재 시장 상황, 최신 동향 및 성장요인, 그리고 전반적인 시장 환경에 대한 최신 분석을 제공합니다. 이 시장의 성장은 차세대 염기서열 분석 및 유전체 데이터의 보급, 임상 워크플로우에 AI 및 ML의 통합, 그리고 전 세계적으로 암 및 만성 질환의 유병률 증가에 힘입어 이루어지고 있습니다.
본 조사는 업계 주요 관계자들의 의견을 포함한 1차 정보와 2차 정보를 객관적으로 종합하여 실시되었습니다. 본 보고서에는 주요 기업에 대한 분석 외에도 종합적인 시장 규모 데이터, 지역별 분석을 포함한 부문별 데이터, 그리고 공급업체 현황이 수록되어 있습니다. 이 보고서에는 과거 데이터와 예측 데이터가 포함되어 있습니다.
| 시장 범위 | |
|---|---|
| 기준연도 | 2025년 |
| 종료연도 | 2030년 |
| 조사 기간 | 2026-2030년 |
| 성장 모멘텀 | 가속 |
| YOY 2026 | 9.8% |
| CAGR | 10.9% |
| 증가액 | 14억 9,670만 달러 |
본 조사에서는 전자건강기록(EHR)과 유전체 플랫폼의 표준화 및 상호운용성이 향후 몇 년간 전 세계 정밀 의료 소프트웨어 시장의 성장을 견인할 주요 요인 중 하나라고 밝혔습니다. 또한, 1차 진료 분야에서 약리유전체학 의사결정 지원 시스템의 보급과 분산형이며 다양한 임상시험에 정밀 의료 소프트웨어를 통합함으로써, 시장에서 상당한 수요가 발생할 것으로 예측됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
제3장 시장 구도
제4장 시장 규모
제5장 시장 규모 실적
제6장 정성 분석
제7장 Five Forces 분석
제8장 시장 세분화 : 컴포넌트별
제9장 시장 세분화 : 최종사용자별
제10장 시장 세분화 : 전개 형태별
제11장 고객 현황
제12장 지역별 상황
제13장 성장 촉진요인, 과제 및 기회
제14장 경쟁 구도
제15장 경쟁 분석
제16장 부록
LSHThe global precision medicine software market is forecasted to grow by USD 1496.7 mn during 2025-2030, accelerating at a CAGR of 10.9% during the forecast period. The report on the global precision medicine software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by proliferation of next-generation sequencing and genomic data, integration of ai and ml in clinical workflows, rising global prevalence of oncology and chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 9.8% |
| CAGR | 10.9% |
| Incremental Value | $1496.7 mn |
Technavio's global precision medicine software market is segmented as below:
By Component
- Software
- Services
By End-User
- Hospitals and clinics
- Pharma and biotech companies
- Diagnostic laboratories
- Contract research organizations
- Others
By Deployment
- Cloud-based
- On-premises
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Russia
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the standardization and interoperability of ehr with genomic platforms as one of the prime reasons driving the global precision medicine software market growth during the next few years. Also, proliferation of pharmacogenomic decision support systems in primary care and integration of precision software in decentralized and diverse clinical trials will lead to sizable demand in the market.
The report on the global precision medicine software market covers the following areas:
- Global precision medicine software market sizing
- Global precision medicine software market forecast
- Global precision medicine software market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global precision medicine software market vendors that include 2bPrecise, Agilent Technologies Inc., Epic Systems Corp., Fabric Genomics Inc., Flatiron Health, GE HealthCare Technologies, GenomOncology LLC, IBM Corp., Illumina Inc., Konica Minolta Inc., Koninklijke Philips NV, McKesson Corp., Myriad Genetics Inc., Oracle Corp., QIAGEN N.V., SOPHiA GENETICS, Tempus AI Inc., Thermo Fisher Scientific Inc., Translational Software Inc, Velsera Inc. Also, the global precision medicine software market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Component
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Deployment
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Precision Medicine Software Market 2020 - 2024
- Historic Market Size - Data Table on Global Precision Medicine Software Market 2020 - 2024 ($ million)
- 5.2 Component segment analysis 2020 - 2024
- Historic Market Size - Component Segment 2020 - 2024 ($ million)
- 5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.4 Deployment segment analysis 2020 - 2024
- Historic Market Size - Deployment Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Precision Medicine Software Market
- 6.2 Impact of Geopolitical Conflicts on Global Precision Medicine Software Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Component
- 8.1 Market segments
- 8.2 Comparison by Component
- 8.3 Software - Market size and forecast 2025-2030
- 8.4 Services - Market size and forecast 2025-2030
- 8.5 Market opportunity by Component
- Market opportunity by Component ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- 9.2 Comparison by End-user
- 9.3 Hospitals and clinics - Market size and forecast 2025-2030
- 9.4 Pharma and biotech companies - Market size and forecast 2025-2030
- 9.5 Diagnostic laboratories - Market size and forecast 2025-2030
- 9.6 Contract research organizations - Market size and forecast 2025-2030
- 9.7 Others - Market size and forecast 2025-2030
- 9.8 Market opportunity by End-user
- Market opportunity by End-user ($ million)
10 Market Segmentation by Deployment
- 10.1 Market segments
- 10.2 Comparison by Deployment
- 10.3 Cloud-based - Market size and forecast 2025-2030
- 10.4 On-premises - Market size and forecast 2025-2030
- 10.5 Market opportunity by Deployment
- Market opportunity by Deployment ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.4.7 Russia - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Singapore - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.5.7 Indonesia - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Australia - Market size and forecast 2025-2030
- 12.6.2 Brazil - Market size and forecast 2025-2030
- 12.6.3 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 UAE - Market size and forecast 2025-2030
- 12.6.6 South Africa - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Proliferation of next-generation sequencing and genomic data
- Integration of AI and ML in clinical workflows
- Rising global prevalence of oncology and chronic diseases
- 13.2 Market challenges
- High infrastructure costs and computational integration hurdles
- Stringent and fragmented regulatory frameworks
- Interoperability deficits and lack of standardized data exchange
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Standardization and interoperability of EHR with genomic platforms
- Proliferation of pharmacogenomic decision support systems in primary care
- Integration of precision software in decentralized and diverse clinical trials
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 2bPrecise
- 2bPrecise - Overview
- 2bPrecise - Product / Service
- 2bPrecise - Key offerings
- SWOT
- 15.5 Epic Systems Corp.
- Epic Systems Corp. - Overview
- Epic Systems Corp. - Product / Service
- Epic Systems Corp. - Key offerings
- SWOT
- 15.6 Fabric Genomics Inc.
- Fabric Genomics Inc. - Overview
- Fabric Genomics Inc. - Product / Service
- Fabric Genomics Inc. - Key offerings
- SWOT
- 15.7 GE HealthCare Technologies
- GE HealthCare Technologies - Overview
- GE HealthCare Technologies - Business segments
- GE HealthCare Technologies - Key news
- GE HealthCare Technologies - Key offerings
- GE HealthCare Technologies - Segment focus
- SWOT
- 15.8 GenomOncology LLC
- GenomOncology LLC - Overview
- GenomOncology LLC - Product / Service
- GenomOncology LLC - Key offerings
- SWOT
- 15.9 IBM Corp.
- IBM Corp. - Overview
- IBM Corp. - Business segments
- IBM Corp. - Key news
- IBM Corp. - Key offerings
- IBM Corp. - Segment focus
- SWOT
- 15.10 Illumina Inc.
- Illumina Inc. - Overview
- Illumina Inc. - Business segments
- Illumina Inc. - Key news
- Illumina Inc. - Key offerings
- Illumina Inc. - Segment focus
- SWOT
- 15.11 Koninklijke Philips NV
- Koninklijke Philips NV - Overview
- Koninklijke Philips NV - Business segments
- Koninklijke Philips NV - Key news
- Koninklijke Philips NV - Key offerings
- Koninklijke Philips NV - Segment focus
- SWOT
- 15.12 Oracle Corp.
- Oracle Corp. - Overview
- Oracle Corp. - Business segments
- Oracle Corp. - Key news
- Oracle Corp. - Key offerings
- Oracle Corp. - Segment focus
- SWOT
- 15.13 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key offerings
- SWOT
- 15.14 SOPHiA GENETICS
- SOPHiA GENETICS - Overview
- SOPHiA GENETICS - Product / Service
- SOPHiA GENETICS - Key offerings
- SWOT
- 15.15 Tempus AI Inc.
- Tempus AI Inc. - Overview
- Tempus AI Inc. - Product / Service
- Tempus AI Inc. - Key offerings
- SWOT
- 15.16 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
- 15.17 Translational Software Inc
- Translational Software Inc - Overview
- Translational Software Inc - Product / Service
- Translational Software Inc - Key offerings
- SWOT
- 15.18 Velsera Inc
- Velsera Inc - Overview
- Velsera Inc - Product / Service
- Velsera Inc - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
